The Entourage Effect in Magic Mushrooms
The combined action of magic mushroom compounds may produce the overall psychedelic experience.
Articles - Page 34
TheraPsil Seeks Permission From Health Canada to Use Psilocybin Treatments for Dying Patients
Bruce Tobin is asking Health Canada to approve psilocybin to treat anxiety and depression in end-of-life patients.
The Pharmacology of Psilocybin and Psilocin
Enter the fascinating world of the chemistry and biology of these psychedelics.
Analysis of the Future Psilocybin Pharmaceutical Market
FDA approval for psilocybin-assisted therapy for depression appears to be on the horizon.
The Receptor Affinity and Chemistry of Bufotenin and Bufotenidine
Don't be confused by the similar spelling and chemical structure. These are two very distinct compounds.
Studying the Effects of Baeocystin
The importance of baeocystin in the overall effects of magic mushrooms is not understood and often overlooked. Here are some ideas to help fill the research gap.
Psilocybin For Smoking Cessation Works Via Drug and Non-Drug Factors
Psilocybin-assisted therapy is showing promise for quitting smoking, but how does it work?
New Discoveries in Magic Mushroom Enzymes
As researchers watch, magic mushrooms are revealing their secrets.
Research and Development of 5-HT3 Agonist Drugs
Pharma companies with expertise in 5-HT3 receptors are focusing on antagonist drugs to combat nausea and vomiting in chemotherapy patients.
Chemical Composition Variability in Magic Mushrooms
Many factors are at play in creating the mysterious cocktail of psychoactive chemicals found in magic mushrooms.